Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Wolf Dietrich Huber"'
Autor:
Maria Noelle Hüpper, Judith Pichler, Wolf-Dietrich Huber, Andreas Heilos, Rebecca Schaup, Martin Metzelder, Sophie Langer
Publikováno v:
Children, Vol 10, Iss 6, p 949 (2023)
(1) Background: Progressive familial intrahepatic cholestasis (PFIC) is a rare cause of liver failure. Surgical biliary diversion (SBD) and ileal bile salt inhibitors (IBAT) can delay or prevent liver transplantation (LTX). A comparison of the two me
Externí odkaz:
https://doaj.org/article/71810b876ad446c3845cfb8ce051358f
Autor:
Azadeh Hojreh, Ahmed Ba-Ssalamah, Christian Lang, Sarah Poetter-Lang, Wolf-Dietrich Huber, Dietmar Tamandl
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Purpose Gd-EOB-DTPA-enhanced liver MRI is frequently compromised by transient severe motion artifacts (TSM) in the arterial phase, which limits image interpretation for the detection and differentiation of focal liver lesions and for the recognition
Externí odkaz:
https://doaj.org/article/98bd57fb879b42a0ba93c6441cc9109e
Autor:
Anna Füreder, Gabriele Kropshofer, Martin Benesch, Michael Dworzak, Sabine Greil, Wolf‐Dietrich Huber, Holger Hubmann, Anita Lawitschka, Georg Mann, Ina Michel‐Behnke, Thomas Müller‐Sacherer, Herbert Pichler, Ingrid Simonitsch‐Klupp, Wolfgang Schwinger, Zsolt Szepfalusi, Roman Crazzolara, Andishe Attarbaschi, Austrian Society of Pediatric Hematology and Oncology
Publikováno v:
Cancer Reports, Vol 4, Iss 5, Pp n/a-n/a (2021)
Abstract Background Management of pediatric post‐transplantation lymphoproliferative disorder (PTLD) after hematopoietic stem cell (HSCT) and solid organ transplantation (SOT) is challenging. Aim This study of 34 PTLD patients up to 19‐years old
Externí odkaz:
https://doaj.org/article/b368d57acb5646e5b1dfbf60b31fdc3e
Autor:
Ana‐Iris Schiefer, Elisabeth Salzer, Anna Füreder, Zsolt Szepfalusi, Thomas Müller‐Sacherer, Wolf‐Dietrich Huber, Ina Michel‐Behnke, Anita Lawitschka, Herbert Pichler, Georg Mann, Caroline Hutter, Ingrid Simonitsch‐Klupp, Andishe Attarbaschi
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4656-4668 (2019)
Abstract Therapy of children with post‐transplantation lymphoproliferative disorder (PTLD) after hematopoietic stem cell (HSCT) and solid organ transplantation (SOT) can be challenging. In this retrospective study, we investigated PD‐L1 and PD1 e
Externí odkaz:
https://doaj.org/article/79fa10133c024536ad1fc07a8e3ab4c3
Autor:
Nina K. Serwas, Birgit Hoeger, Rico C. Ardy, Sigrun V. Stulz, Zhenhua Sui, Nima Memaran, Marie Meeths, Ana Krolo, Özlem Yüce Petronczki, Laurène Pfajfer, Tie Z. Hou, Neil Halliday, Elisangela Santos-Valente, Artem Kalinichenko, Alan Kennedy, Emily M. Mace, Malini Mukherjee, Bianca Tesi, Anna Schrempf, Winfried F. Pickl, Joanna I. Loizou, Renate Kain, Bettina Bidmon-Fliegenschnee, Jean-Nicolas Schickel, Salomé Glauzy, Jakob Huemer, Wojciech Garncarz, Elisabeth Salzer, Iro Pierides, Ivan Bilic, Jens Thiel, Peter Priftakis, Pinaki P. Banerjee, Elisabeth Förster-Waldl, David Medgyesi, Wolf-Dietrich Huber, Jordan S. Orange, Eric Meffre, David M. Sansom, Yenan T. Bryceson, Amnon Altman, Kaan Boztug
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
CTLA-4 is critical for balancing protective immunity with self-tolerance. Here the authors identify homozygous DEF6 mutations in patients with severe autoimmunity, one of which received and responds to CTLA-4-Ig, and show that DEF6 is crucial for CTL
Externí odkaz:
https://doaj.org/article/2b28c1d1ae924d86a02c99db5aac2d80
Autor:
Anna-Maria Schneider, Daniel Weghuber, Benjamin Hetzer, Andreas Entenmann, Thomas Müller, Georg Zimmermann, Sebastian Schütz, Wolf-Dietrich Huber, Judith Pichler
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Vedolizumab is safe and effective in adult patients with Crohn’s disease (CD) and ulcerative colitis (UC); however, data in children with inflammatory bowel disease (IBD) are scarce. Therefore, we evaluated vedolizumab use in a
Externí odkaz:
https://doaj.org/article/feabd32870b64cf9914dd01234eeba1d
Autor:
Nina K. Serwas, Birgit Hoeger, Rico C. Ardy, Sigrun V. Stulz, Zhenhua Sui, Nima Memaran, Marie Meeths, Ana Krolo, Özlem Yüce Petronczki, Laurène Pfajfer, Tie Z. Hou, Neil Halliday, Elisangela Santos-Valente, Artem Kalinichenko, Alan Kennedy, Emily M. Mace, Malini Mukherjee, Bianca Tesi, Anna Schrempf, Winfried F. Pickl, Joanna I. Loizou, Renate Kain, Bettina Bidmon-Fliegenschnee, Jean-Nicolas Schickel, Salomé Glauzy, Jakob Huemer, Wojciech Garncarz, Elisabeth Salzer, Iro Pierides, Ivan Bilic, Jens Thiel, Peter Priftakis, Pinaki P. Banerjee, Elisabeth Förster-Waldl, David Medgyesi, Wolf-Dietrich Huber, Jordan S. Orange, Eric Meffre, David M. Sansom, Yenan T. Bryceson, Amnon Altman, Kaan Boztug
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-2 (2019)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/2ad5e2b7ab8840e49f562084ad81cfe1
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:274-280
Lactose malabsorption and lactose-induced symptoms are poorly correlated, as shown by breath tests and various symptom assessment methods. Validated assessment is the key to overcome the limitations of biased symptom measurements. We characterized la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4c3d682c96d89a1b9a1978cbb2bf74
https://doi.org/10.1097/meg.0000000000002283
https://doi.org/10.1097/meg.0000000000002283
Autor:
Katharina Woeran, Leo Kager, Kaan Boztug, Judith Stift, Karoly Lakatos, Wolf-Dietrich Huber, Hubert Kogler, Andreas Vécsei, Wolfgang Novak, Christina Zachbauer
Publikováno v:
Clinical Journal of Gastroenterology
Autoimmune pancreatitis is a rare, distinct and increasingly recognized form of chronic inflammatory pancreatic disease secondary to an underlying autoimmune mechanism. We report on a 14-year-old boy who developed autoimmune pancreatitis, while he wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78346e518eb93ffd4857835c047e195a
http://europepmc.org/articles/PMC8154769
http://europepmc.org/articles/PMC8154769
Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
Autor:
Christoph Aufricht, Judith Pichler, Bettina Bidmon-Fliegenschnee, Wolf Dietrich Huber, Nima Memaran
Publikováno v:
Acta Paediatrica (Oslo, Norway : 1992)
Aim Anti‐tumour necrosis factor (TNF)‐α drugs are effective treatments for the management of moderate/severe Crohn's disease (CD), but treatment failure is common. In the treatment of paediatric CD, there are no data about the use of a third int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::825c0c4413d8a67bbbaed67b224aea85
http://europepmc.org/articles/PMC7891654
http://europepmc.org/articles/PMC7891654